Strong Outcomes in Fistulising Crohn’s Disease Patients

Latest ADHD Research

Dr Ross Walker talk to Dr Tanveer Ahmed about the latest ADHD research.  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Potential delay of the onset of clinical Type 1 diabetes

Dr Ross Walker speaks with Professor John Wentworth, Endocrinologist and Senior Clinical Research Fellow at St Vincent's Institute of Medical Research. We discuss the TGA’s historic registration of Tzield, the very first non-insulin medicine designed to delay the onset of clinical Type 1 diabetes. To find out more go to https://breakthrought1d.org.au/news/tzield-approved-in-australia/ [https://breakthrought1d.org.au/news/tzield-approved-in-australia/]  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

MND Fundraiser

Dr. Ross Walker speaks with Bob Montgomery about his fundraiser for Motor Neurone Disease. To track his trip from Broome to Bowral, go to https://bobmontgomery.com.au [https://bobmontgomery.com.au] . See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Strong Outcomes in Fistulising Crohn’s Disease Patients

Dr Ross Walker interviews medical expert Dr. Marian Sturm to explore a promising breakthrough for fistulising Crohn’s disease, a notoriously debilitating and hard-to-treat complication of inflammatory bowel disease.  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Healthy Living - 07 June 2026

See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.